Document Detail

Paecilomyces lilacinus peritonitis complicating peritoneal dialysis cured by oral voriconazole and terbinafine combination therapy.
MedLine Citation:
PMID:  19018033     Owner:  NLM     Status:  MEDLINE    
Fungal peritonitis (FP) is a serious complication in patients on continuous ambulatory peritoneal dialysis (CAPD). We report a case of CAPD-related FP caused by Paecilomyces lilacinus in a 15-year-old uraemic boy. The infection was successfully treated by combination therapy consisting of oral voriconazole and terbinafine, which has not been previously reported in the treatment of FP.
Brian Pin-Hsuan Chang; Pei-Lun Sun; Fu-Yuan Huang; Tsuen-Chiuan Tsai; Chun-Chen Lin; Ming-Dar Lee; Yee-Chun Chen; Jin-Cherng Sheu; Jeng-Daw Tsai
Related Documents :
1543783 - Chemical peritonitis following the intraperitoneal administration of vancomycin.
24128683 - Adult-onset leukodystrophy: review of 3 clinicopathologic phenotypes and a proposed cla...
19055793 - Avascular necrosis of humeral head in an elderly patient with tuberculosis: a case report.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of medical microbiology     Volume:  57     ISSN:  0022-2615     ISO Abbreviation:  J. Med. Microbiol.     Publication Date:  2008 Dec 
Date Detail:
Created Date:  2008-11-21     Completed Date:  2009-01-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0224131     Medline TA:  J Med Microbiol     Country:  England    
Other Details:
Languages:  eng     Pagination:  1581-4     Citation Subset:  IM    
Department of Pediatrics, Mackay Memorial Hospital, Taipei, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Antifungal Agents* / administration & dosage,  therapeutic use
Drug Therapy, Combination
Mycoses / drug therapy,  microbiology
Naphthalenes* / administration & dosage,  therapeutic use
Paecilomyces / drug effects,  isolation & purification*
Peritoneal Dialysis, Continuous Ambulatory / adverse effects*
Peritonitis / drug therapy*,  microbiology
Pyrimidines* / administration & dosage,  therapeutic use
Treatment Outcome
Triazoles* / administration & dosage,  therapeutic use
Reg. No./Substance:
0/Antifungal Agents; 0/Naphthalenes; 0/Pyrimidines; 0/Triazoles; 0/voriconazole; 91161-71-6/terbinafine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Antimicrobial susceptibility testing of Bordetella pertussis in Taiwan prompted by a case of pertuss...
Next Document:  Persistent Candida parapsilosis funguria associated with an indwelling urinary tract stent for more ...